PlainRecalls
FDA Drug Moderate Class II Terminated

DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.

Reported: August 7, 2019 Initiated: April 24, 2019 #D-1583-2019

Product Description

DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.

Reason for Recall

cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.

Details

Recalling Firm
MAJOR PHARMACEUTICALS
Units Affected
828 100-count unit dose cartons
Distribution
Nationwide in the USA
Location
Livonia, MI

Frequently Asked Questions

What product was recalled?
DIVALPROEX SODIUM EXTENDED-RELEASE TABLETS, USP Tablets, 250 mg, 100 count-unit dose carton, RX only, Manufactured by Dr. Reddy's Laboratories Ltd. Bachupally - 500 090 India. Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152. NDC # 0904-6363-61.. Recalled by MAJOR PHARMACEUTICALS. Units affected: 828 100-count unit dose cartons.
Why was this product recalled?
cGMP deviations: Product was exposed above 50% relative humidity levels during packaging operations.
Which agency issued this recall?
This recall was issued by the FDA Drug on August 7, 2019. Severity: Moderate. Recall number: D-1583-2019.